In vivo and in vitro characterization of a Plasmodium liver stage-specific promoter

PLoS One. 2015 Apr 15;10(4):e0123473. doi: 10.1371/journal.pone.0123473. eCollection 2015.

Abstract

Little is known about stage-specific gene regulation in Plasmodium parasites, in particular the liver stage of development. We have previously described in the Plasmodium berghei rodent model, a liver stage-specific (lisp2) gene promoter region, in vitro. Using a dual luminescence system, we now confirm the stage specificity of this promoter region also in vivo. Furthermore, by substitution and deletion analyses we have extended our in vitro characterization of important elements within the promoter region. Importantly, the dual luminescence system allows analyzing promoter constructs avoiding mouse-consuming cloning procedures of transgenic parasites. This makes extensive mutation and deletion studies a reasonable approach also in the malaria mouse model. Stage-specific expression constructs and parasite lines are extremely valuable tools for research on Plasmodium liver stage biology. Such reporter lines offer a promising opportunity for assessment of liver stage drugs, characterization of genetically attenuated parasites and liver stage-specific vaccines both in vivo and in vitro, and may be key for the generation of inducible systems.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 5' Untranslated Regions / genetics
  • Animals
  • Carcinoma, Hepatocellular / genetics
  • Carcinoma, Hepatocellular / metabolism
  • Carcinoma, Hepatocellular / pathology
  • Cell Line, Tumor
  • Female
  • Humans
  • Liver / parasitology*
  • Liver Neoplasms / genetics
  • Liver Neoplasms / metabolism
  • Liver Neoplasms / pathology
  • Luciferases / genetics
  • Luciferases / metabolism
  • Luminescent Measurements / methods
  • Malaria / parasitology
  • Mice, Inbred BALB C
  • Mutation
  • Plasmodium berghei / genetics*
  • Plasmodium berghei / metabolism
  • Promoter Regions, Genetic / genetics*
  • Protozoan Proteins / genetics*
  • Sequence Deletion

Substances

  • 5' Untranslated Regions
  • Protozoan Proteins
  • Luciferases

Grants and funding

This work was supported by the Swiss National Foundation grant to VH (310030_140691/1), the Swiss SystemsX Consortium and European Union's Seventh Framework Programme (FP7/2007–2013) under grant agreement 242095: EVIMalaR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.